VIDEO: Review finds visual improvements in anti-VEGF for diabetic retinopathy

CHICAGO — At the American Society of Retina Specialists meeting, Rishi P. Singh, MD, of the Cole Eye Institute at the Cleveland Clinic, discusses a retrospective review of the VISTA and VIVID studies looking at visual improvements in patients receiving anti-VEGF treatment for diabetic retinopathy.

Full Story →